| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $27.0M | +32.9% |
| Cost of Revenue | $13.8M | -4.1% |
| Gross Profit | $13.3M | +121.7% |
| R&D Expense | $24.2M | +19.4% |
| SG&A Expense | $20.5M | +12.9% |
| Operating Income | -$57.7M | -2.8% |
| Pre-tax Income | -$44.6M | +24.9% |
| Income Tax | -$1.9M | -2993.8% |
| Net Income | -$42.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $27.8M | -24.5% |
| Accounts Receivable | $4.8M | +52.3% |
| Inventory | $4.8M | -6.1% |
| Current Assets | $40.5M | -14.4% |
| Total Assets | $118.9M | +23.3% |
| Current Liabilities | $16.6M | +33.2% |
| Long-term Debt | $23.5M | -4.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$38.6M | -26.9% |
| Capital Expenditures | $138K | -76.4% |
| Investing Cash Flow | -$8.9M | -1533.3% |
| Financing Cash Flow | $38.5M | +111.1% |
| Free Cash Flow | -$38.7M | -25.0% |
| +28.1% |
| EPS (Basic) | $0.61 | -68.4% |
| EPS (Diluted) | $0.61 | -68.4% |
| Stockholders' Equity |
| $72.0M |
| +23.9% |